Dermira, Inc. clinical trials
Acquired by Eli Lilly and Company, Feb 20, 2020 · source ↗
The registry lists 10 studies whose lead sponsor is Dermira, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 20, 2021.
- 10studies on the registry
- 0open to participants now
Before and after it joined Eli Lilly and Company
- First submitted before Dermira, Inc. became part of Eli Lilly and Company
- 10
- First submitted after Dermira, Inc. became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Dermira, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 3
All 10 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed10100%
Over the years
- 11
- 12
- 513
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Dermira, Inc.10 studies
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Eli Lilly and Company studies →
- A Safety and Efficacy of DRM02 in Subjects With Atopic DermatitisCompletedNCT01993420Phase 2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03073486Phase 3
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical GelCompletedNCT01936324Phase 1/2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Safety and Efficacy Study of DRM02 in Subjects With RosaceaCompletedNCT01993446Phase 2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03028363Phase 3
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild AcneCompletedNCT01490736Phase 1/2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- Open-label Safety and Tolerability Study of LTS-PDT in Healthy VolunteersCompletedNCT01830764Phase 1
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Dose-ranging Study of DRM01 in Subjects With Acne VulgarisCompletedNCT02431052Phase 2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne VulgarisCompletedNCT03127956Phase 3
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company
- A Safety and Efficacy Study of DRM02 in Subjects With Plaque PsoriasisCompletedNCT01993433Phase 2
Sponsor listed in the registry: Dermira, Inc. · First submitted before Dermira, Inc. became part of Eli Lilly and Company